Redeye updates on Gentoo Media after Q2-results which were weaker than expected as topline continued...
Redeye takes a positive stance towards the divestment of Netgain at 12x EBITDA, far above CombinedX ...
Redeye returns with updated estimates and valuation following Sleep Cycle's Q2 2026 report, presenta...
* Orders +5%, adj. EBITA +5% above us on higher Power margin * '26e-'28e adj.
InfraCom missed on both net sales and EBITA in Q2 2026 against an easy comparable.
Redeye provides a research update following the Q2 report recently published by AlzeCure.
Mendus’s Q226 results highlighted continued execution of its broadened vididencel strategy, with the...
* VDL Groep and SMRX to sign the first ADES Test Loop project * The project implies a further step t...
Redeye notes that Smart Eye's Q2 2026 report fell short of our expectations, with the miss driven en...
Redeye provides an initial take following the release of Corline’s Q2 2026 report.
InfraCom’s Q2 2026 report fell short of expectations against an easy comparable, with net sales grow...
Redeye comments on Gentoo Media’s Q2-results which were softer than expected while the company trimm...
Redeye considers GomSpace's H1 2026 report to be solid, with revenue of SEK239m (+30% y/y) landing s...
Redeye takes a positive stance towards q.beyond's buybacks, which we believe is a value-creating cap...
* Agreement reached with the chemical company * Candy producer delays panel testing * We keep our fa...
Redeye's initial take on Sleep Cycle's Q2 2026 report is that the underlying quarter was broadly in ...
Acenta reported net sales of SEK 5.5 million (1.5) in Q2’26, while gross profit improved to SEK 0.
Solwers' Q2 results remained weak, with profitability still at an unsatisfactory level.
Management continues to execute well, and to adhere pretty closely to its timelines.
Actic delivered further progress in Q2, with ARPM up y/y, despite the Norwegian operations still bei...
